This type of stock will often retrace some during relatively quiet periods and then spike when really good news is released... this is a relatively quiet period... this stock will be driven significantly higher by three news releases over the next few months... imo... positive findings regarding biomarker 21 in p1 kevetrin trial... presentation of findings from p1 at ASCO... and the announcement of the ind for purisol... likely to be a $3 to $5 stock following these events by late summer... and that will just form the launching pad for what comes after...
As long as volume remains low during this slow retracement... I don't worry about it... hoping it continues a little longer... I am not quite done accumulating...
Market Data 
Markets 
AI
